Literature DB >> 22057973

Role of interleukin-10 in breast cancer.

Bendangla Changkija, Rituraj Konwar.   

Abstract

Cytokines are low molecular weight regulatory proteins or glycoprotein that modulates the intensity and duration of immune response by stimulating or inhibiting the activation, proliferation, and/or differentiation of target cells. Different cytokines are known to have diverse role in breast cancer initiation and progression. Interleukin-10 (IL-10), a pleiotropic anti-inflammatory cytokine, induces immunosuppression and assists in escape from tumor immune surveillance. Like several other cytokines, IL-10 also can exert dual proliferative and inhibitory effect on breast tumor cells indicating a complex role of IL-10 in breast cancer initiation and progression. In this review, we tried to put together a comprehensive current view on significance of IL-10 in promotion, inhibition, and importance as prognosticator in breast cancer based on in vitro, in vivo, and clinical evidences. For literature collection, we conducted PubMed search with keywords "IL-10" and "breast cancer".

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22057973     DOI: 10.1007/s10549-011-1855-x

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  72 in total

1.  Emotional acceptance, inflammation, and sickness symptoms across the first two years following breast cancer diagnosis.

Authors:  Rebecca G Reed; Karen L Weihs; David A Sbarra; Elizabeth C Breen; Michael R Irwin; Emily A Butler
Journal:  Brain Behav Immun       Date:  2016-02-23       Impact factor: 7.217

2.  Induction of the MCP chemokine cluster cascade in the periphery by cancer cell-derived Ccl3.

Authors:  Elena Farmaki; Vimala Kaza; Athanasios G Papavassiliou; Ioulia Chatzistamou; Hippokratis Kiaris
Journal:  Cancer Lett       Date:  2016-12-29       Impact factor: 8.679

3.  The Influence of Biomaterials on Cytokine Production in 3D Cultures.

Authors:  Mary C Regier; Sara I Montanez-Sauri; Michael P Schwartz; William L Murphy; David J Beebe; Kyung Eun Sung
Journal:  Biomacromolecules       Date:  2017-02-16       Impact factor: 6.988

Review 4.  The role of cytokines in breast cancer development and progression.

Authors:  Marcela Esquivel-Velázquez; Pedro Ostoa-Saloma; Margarita Isabel Palacios-Arreola; Karen E Nava-Castro; Julieta Ivonne Castro; Jorge Morales-Montor
Journal:  J Interferon Cytokine Res       Date:  2014-07-28       Impact factor: 2.607

5.  Relationship between IL-10 expression and prognosis in patients with primary breast cancer.

Authors:  Ying Li; Ping Gao; Junlan Yang; Haiming Yu; Yanyun Zhu; Wen Si
Journal:  Tumour Biol       Date:  2014-08-17

Review 6.  Harnessing the immune system for the treatment of breast cancer.

Authors:  Xinguo Jiang
Journal:  J Zhejiang Univ Sci B       Date:  2014-01       Impact factor: 3.066

7.  Association of serum interleukin-10, interleukin-17A and transforming growth factor-α levels with human benign and malignant breast diseases.

Authors:  Zhuangwei Lv; Min Liu; Jinghui Shen; Dong Xiang; Yunfeng Ma; Yanhong Ji
Journal:  Exp Ther Med       Date:  2018-04-30       Impact factor: 2.447

8.  Health Promoting Life-Style Behaviors and Systemic Inflamma-tion in African American and Caucasian Women Prior to Chemo-therapy for Breast Cancer.

Authors:  Debra E Lyon; Lathika Mohanraj; Debra Lynch Kelly; Rk Elswick
Journal:  Health Promot Perspect       Date:  2014-07-12

9.  Cytokines secreted by macrophages isolated from tumor microenvironment of inflammatory breast cancer patients possess chemotactic properties.

Authors:  Mona M Mohamed; Eslam A El-Ghonaimy; Mohamed A Nouh; Robert J Schneider; Bonnie F Sloane; Mohamed El-Shinawi
Journal:  Int J Biochem Cell Biol       Date:  2013-11-26       Impact factor: 5.085

10.  Celecoxib and fish oil: a combination strategy for decreased inflammatory mediators in early stages of experimental mammary cancer.

Authors:  Anjana Kumari Negi; Archana Bhatnagar; Navneet Agnihotri
Journal:  Inflammopharmacology       Date:  2016-01-09       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.